Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

75%

Ph phase_1

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

1(25.0%)

N/ANon-phased studies

3(75.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Terminated(1)

Other(1)

Detailed Status

Completed2

Withdrawn1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 11 (25.0%)

N/A3 (75.0%)

Trials by Status

completed250%

withdrawn125%

unknown125%

Recent Activity

0 active trials

Showing 4 of 4

completednot_applicable

Group Version of the UP-A in a Spanish Public Mental Health Setting.

NCT06894368

completednot_applicable

Group Version of the UP-A in a Spanish Day Hospital for Adolescents.

NCT06894394

unknownnot_applicable

Efficacy of the Unified Protocol for the Transdiagnostic Treatment (UP-A; Ehrenreich-May et al., 2018) for Adolescents With Moderate Emotional Symptoms in Educational Settings

NCT05322642

withdrawnphase_1

Quality of Life Outcomes for Ulipristal Acetate and Tranexamic Acid in the Management of Heavy Menstrual Bleeding

NCT03027973

Clinical Trials (4)

Showing 4 of 4 trials

NCT06894368Not Applicable

Group Version of the UP-A in a Spanish Public Mental Health Setting.

Completed

NCT06894394Not Applicable

Group Version of the UP-A in a Spanish Day Hospital for Adolescents.

Completed

NCT05322642Not Applicable

Efficacy of the Unified Protocol for the Transdiagnostic Treatment (UP-A; Ehrenreich-May et al., 2018) for Adolescents With Moderate Emotional Symptoms in Educational Settings

Unknown

NCT03027973Phase 1

Quality of Life Outcomes for Ulipristal Acetate and Tranexamic Acid in the Management of Heavy Menstrual Bleeding

Withdrawn

All 4 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 4